Pa. Federal Court Picks Trial Suits In Zoloft Birth Defect MDL

Law360, New York (May 5, 2015, 7:53 PM EDT) -- A Pennsylvania federal judge on Monday selected five cases to go to trial in the ongoing federal multidistrict litigation involving allegations that Pfizer Inc.'s antidepressant Zoloft can cause heart defects in children born to those taking the drug during pregnancy. 

U.S. District Judge Cynthia Rufe selected the five cases for the initial trial pool, with trials scheduled to begin in January 2016, according to court documents. The first trial in the federal MDL involves claims by plaintiff Deidra Long, who had filed her suit in Pennsylvania state court in May 2012.

She alleges that exposure to Zoloft during her pregnancy caused...

Stay ahead of the curve

In the legal profession, information is the key to success. You have to know what’s happening with clients, competitors, practice areas, and industries. Law360 provides the intelligence you need to remain an expert and beat the competition.


  • Access to case data within articles (numbers, filings, courts, nature of suit, and more.)
  • Access to attached documents such as briefs, petitions, complaints, decisions, motions, etc.
  • Create custom alerts for specific article and case topics and so much more!

TRY LAW360 FREE FOR SEVEN DAYS

Hello! I'm Law360's automated support bot.

How can I help you today?

For example, you can type:
  • I forgot my password
  • I took a free trial but didn't get a verification email
  • How do I sign up for a newsletter?
Beta
Ask a question!